Jackson Square Capital, LLC Ascendis Pharma A/S Transaction History

Jackson Square Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$124.92 - $173.33 $265,829 - $368,846	-2,128 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$134.29 - $154.32 $61,504 - $70,678	-458 Reduced 17.71%	2,128 $328,000
Q2 2020 Aug 18, 2020	BUY	$110.87 - $156.01 $179,055 - $251,956	1,615 Added 166.32%	2,586 $382,000
Q1 2020 May 15, 2020	BUY	$97.01 - $145.11 $40,356 - $60,365	416 Added 74.95%	971 $109,000
Q4 2019 May 15, 2020	BUY	$91.45 - $139.12 $50,754 - $77,211	555 New	555 $77,000

223

56.5M

142K

259K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.97B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.